Name: TRADE Study Presented by Erica Mayer, MD.
Uploaded: 2025-06-11T00:00:00+00:00
Description: Dr. Erica Mayer shares results from the TRADE study showing a successful abemaciclib dose escalation strategy in patients with HR+ breast cancer.

Dr. Erica Mayer shares results from the TRADE study showing a successful abemaciclib dose escalation strategy in patients with HR+ breast cancer.

Related Presenters

Erica Mayer, MD, MPH

Institute Physician
Assistant Professor of Medicine, Harvard Medical School

Dr. Mayer received her medical degree from Harvard Medical School in 2000. She subsequently completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at Dana-Farber Cancer Institute. ...

View full profile